AVXL
ANAVEX LIFE SCIENCES CORP.
Key Financials
Operating Income
$-51408000
↑ 2.8%
Net Income
$-46377000
↓ 7.8%
EPS (Diluted)
$-0.54
↓ 3.8%
Total Assets
$103.8M
↓ 23.4%
Cash & Equivalents
$102.6M
↓ 22.4%
Total Liabilities
$8.9M
↓ 41.5%
Long-term Debt
$332.00
0.0%
Shareholders' Equity
$94.9M
↓ 21.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AVXL |
| Company Name | ANAVEX LIFE SCIENCES CORP. |
| CIK | 1314052 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| Phone | 844-689-3939 |